A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

Author： Casal Rubio J.   Fírvida-Pérez J.   Lázaro-Quintela M.   Barón-Duarte F.   Alonso-Jáudenes G.   Santomé L.   Afonso-Afonso F.   Amenedo M.   Huidobro G.   Campos-Balea B.   López-Vázquez M.   Vázquez S.  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.73, Iss.3, 2014-03, pp. : 451-457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pre-operative Chemoradiotherapy in Non-small Cell Lung Cancer Stage III Patients. Feasibility, Toxicity and Long-term Results of a Phase II Study

By Favaretto A.   Paccagnella A.   Tomio L.   Sartori F.   Cipriani A.   Zuin R.   Reffosco L.   Calabro' F.   Rea F.   Ghiotto C.   Chiarion-Sileni V.   Oniga F.   Loreggian L.   Fiorentino M.V.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2064-2069

Elsevier

Access to resources Recommend Favorite

Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG0803)

By Wu Y.-L.   Zhou C.   Cheng Y.   Lu S.   Chen G.-Y.   Huang C.   Huang Y.-S.   Yan H.-H.   Ren S.   Liu Y.   Yang J.-J.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 993-999

Oxford University Press

Access to resources Recommend Favorite

Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer

By Solomon B.   Ball D.L.   Richardson G.   Smith J.G.   Millward M.   MacManus M.   Michael M.   Wirth A.   O'Kane C.   Muceniekas L.   Ryan G.   Rischin D.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 353-361

Elsevier

Access to resources Recommend Favorite

Preoperative Concurrent Chemoradiotherapy for Stage IIIA Non-Small Cell Lung Cancer

By Ahn Yong Chan   Park Keunchil   Kim Dae Yong   Kim Kwan Min   Kim Jhingook   Shim Young Mog   Lee Kyung Soo   Han Joungho   Kim Ho Joong   Kwon O Jung   Lim Do Hoon   Noh Young Joo   Lee Jeong Eun   Huh Seung Jae  

Acta Oncologica, Vol. 40, Iss. 5, 2001-09 ,pp. : 588-592

Informa Healthcare

Access to resources Recommend Favorite

A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401

By Oh In-Jae   Kim Kyu-Sik   Kim Young-Chul   Ban Hee-Jung   Kwon Yong-Soo   Kim Yu-Il   Lim Sung-Chul   Chung Woong-Ki   Nam Taek-Keun   Song Joo-Young   Yoon Mee-Sun   Ahn Sung-Ja  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1247-1254

Springer Publishing Company

Access to resources Recommend Favorite